| pubmed-article:19680262 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19680262 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
| pubmed-article:19680262 | lifeskim:mentions | umls-concept:C1704241 | lld:lifeskim |
| pubmed-article:19680262 | lifeskim:mentions | umls-concept:C0439662 | lld:lifeskim |
| pubmed-article:19680262 | lifeskim:mentions | umls-concept:C0851285 | lld:lifeskim |
| pubmed-article:19680262 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19680262 | pubmed:dateCreated | 2009-12-16 | lld:pubmed |
| pubmed-article:19680262 | pubmed:abstractText | There have been a number of recent discoveries relating to the functions of inhibitors of apoptosis (IAPs) and TNF receptor-associated factors (TRAFs) in regulating signalling from TNF receptor superfamily (TNFRSF) members and some tantalizing glimpses into a wider area of influence, that of innate immune signalling. Discoveries relating to the function of these ubiquitin E3 ligases in regulating signalling from the eponymous member of the family, TNF-R1, are dealt with superbly in a separate review by Wertz and Dixit and so we will confine our discussion to the subset of the TNFRSF that does not contain a death domain (DD). In line with the available data we will divide the review into two parts, the first is restricted to the role of TRAFs 2 and 3 and cIAPs in regulating TNFRSF signalling, whereas the second will be more speculative, asking what role IAPs and TRAFs have in innate immune signalling. | lld:pubmed |
| pubmed-article:19680262 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19680262 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19680262 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19680262 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19680262 | pubmed:issn | 1476-5403 | lld:pubmed |
| pubmed-article:19680262 | pubmed:author | pubmed-author:BostaS DSD | lld:pubmed |
| pubmed-article:19680262 | pubmed:author | pubmed-author:SilkeJJ | lld:pubmed |
| pubmed-article:19680262 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19680262 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:19680262 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19680262 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19680262 | pubmed:pagination | 35-45 | lld:pubmed |
| pubmed-article:19680262 | pubmed:dateRevised | 2011-11-2 | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:meshHeading | pubmed-meshheading:19680262... | lld:pubmed |
| pubmed-article:19680262 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19680262 | pubmed:articleTitle | Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. | lld:pubmed |
| pubmed-article:19680262 | pubmed:affiliation | Department of Biochemistry, La Trobe University, Kingsbury Drive, Melbourne, Victoria 3086, Australia. j.silke@latrobe.edu.au | lld:pubmed |
| pubmed-article:19680262 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19680262 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:19680262 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19680262 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19680262 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19680262 | lld:pubmed |
